SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-15-006274
Filing Date
2015-12-16
Accepted
2015-12-16 16:30:54
Documents
5
Period of Report
2015-12-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 43895
2 ex10-1.htm EX-10.1 390022
3 ex10-2.htm EX-10.2 57398
4 ex10-3.htm EX-10.3 96887
5 ex10-4.htm EX-10.4 92564
  Complete submission text file 0001493152-15-006274.txt   682143
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21617 | Film No.: 151291279
SIC: 2834 Pharmaceutical Preparations